Catalyst Event

Boston Scientific Corp (BSX) · Other

From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)

4/26/2026, 12:00:00 AM

OtherSentiment: Positive

Presented positive results from the AVANT GUARD clinical trial at the Heart Rhythm 2026 conference, showing its FARAPULSE Pulsed Field Ablation (PFA) system was superior to drug therapy for persistent atrial fibrillation (Medium importance estimated based on clinical significance); scheduled.

Korean Translation

Heart Rhythm 2026 컨퍼런스에서 AVANT GUARD 임상시험의 긍정적 결과를 발표하며 FARAPULSE PFA 시스템의 우수성을 입증함(임상적 유의성에 따른 Medium 중요도 예상); 예정됨.

Related Recent Events

View Full Timeline